Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Endocrine, Metabolic & Immune Disorders Drug Targets|August 9, 2021
Therapeutic Options for the Management of Aromatase Inhibitor- Associated Bone LossAgostino Gaudio, Anastasia Xourafa, Rosario Rapisarda, et al.Molecular Medicine Reports|October 2, 2018
Peripheral artery disease and osteoporosis: Not only age‑related (Review)Agostino Gaudio, Anastasia Xourafa, Rosario Rapisarda, et al.Journal of Clinical Research in Pediatric Endocrinology|July 12, 2018
Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical ExperienceAgostino Gaudio, Nancy Morabito, Antonino Catalano, et al.Diabetes & Vascular Disease Research|November 15, 2013
The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitusAgostino Gaudio, Filippo Privitera, Ivana Pulvirenti, et al.International Journal of Molecular Sciences|May 21, 2020
Hematological Diseases and OsteoporosisAgostino Gaudio, Anastasia Xourafa, Rosario Rapisarda, et al.Current Vascular Pharmacology|June 10, 2020
Paget's Disease of Bone and Cardiovascular Risk: A Pilot StudyAgostino Gaudio, Luca Zanoli, Anastasia Xourafa, et al.Scientific Reports|November 11, 2020
Early vascular ageing biomarkers in osteoporotic outpatients: a pilot studyAgostino Gaudio, Anastasia Xourafa, Luca Zanoli, et al.Respiratory Medicine Case Reports|August 7, 2019
A strange case of dyspnoeaAgostino Gaudio, Andrea Ruben Murabito, Anastasia Xourafa, et al.Clinical Case Reports|February 18, 2021
Familiar osteopoikilosis: Case report with differential diagnosis and review of the literatureAgostino Gaudio, Anastasia Xourafa, Rosario Rapisarda, et al.Molecular Medicine Reports|March 25, 2017
Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in CataniaAgostino Gaudio, Valerio Fiore, Rosario Rapisarda, et al.Pageof 1